John DeGroot

7.0k total citations · 1 hit paper
32 papers, 3.5k citations indexed

About

John DeGroot is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, John DeGroot has authored 32 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Neurology. Recurrent topics in John DeGroot's work include Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). John DeGroot is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (8 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). John DeGroot collaborates with scholars based in United States, Canada and Switzerland. John DeGroot's co-authors include Patrick Y. Wen, Mark R. Gilbert, Wolfgang Wick, Martin J. van den Bent, Michael A. Vogelbaum, Kathleen R. Lamborn, Marc C. Chamberlain, Timothy F. Cloughesy, David R. Macdonald and David A. Reardon and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John DeGroot

32 papers receiving 3.4k citations

Hit Papers

Updated Response Assessment Criteria for High-Grade Gliom... 2010 2026 2015 2020 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
    2010 2.7k citations Patrick Y. Wen, David R. Macdonald et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John DeGroot United States 15 2.6k 1.3k 848 562 500 32 3.5k
J. C. Tonn Germany 30 2.3k 0.9× 1.2k 0.9× 982 1.2× 584 1.0× 542 1.1× 119 3.6k
Oliver Schnell Germany 31 2.0k 0.8× 949 0.7× 705 0.8× 1.1k 1.9× 637 1.3× 118 3.8k
Melike Pekmezci United States 28 1.4k 0.5× 678 0.5× 744 0.9× 1.3k 2.3× 836 1.7× 101 4.0k
Martin Glas Germany 28 1.5k 0.6× 569 0.4× 635 0.7× 691 1.2× 452 0.9× 151 2.6k
Geoffrey Barger United States 25 1.3k 0.5× 477 0.4× 602 0.7× 349 0.6× 295 0.6× 59 2.0k
Ghazaleh Tabatabai Germany 38 2.7k 1.0× 820 0.6× 926 1.1× 1.9k 3.3× 1.0k 2.0× 183 5.3k
Keishi Makino Japan 27 1.4k 0.5× 701 0.5× 912 1.1× 1.5k 2.7× 583 1.2× 95 4.2k
Fábio M. Iwamoto United States 37 3.0k 1.2× 536 0.4× 1.2k 1.5× 937 1.7× 646 1.3× 148 4.6k
Juan Guillermo Trigo Naranjo Chile 1 2.8k 1.1× 629 0.5× 791 0.9× 1.8k 3.3× 1.2k 2.4× 2 4.7k
M. Kelly Nicholas United States 26 2.8k 1.1× 502 0.4× 1.2k 1.4× 1.6k 2.8× 1.1k 2.1× 64 4.5k

Countries citing papers authored by John DeGroot

Since Specialization
Citations

This map shows the geographic impact of John DeGroot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John DeGroot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John DeGroot more than expected).

Fields of papers citing papers by John DeGroot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John DeGroot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John DeGroot. The network helps show where John DeGroot may publish in the future.

Co-authorship network of co-authors of John DeGroot

This figure shows the co-authorship network connecting the top 25 collaborators of John DeGroot. A scholar is included among the top collaborators of John DeGroot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John DeGroot. John DeGroot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bush, Nancy Ann Oberheim, Jane Rabbitt, Mariza Daras, et al.. (2024). CTIM-31. PRELIMINARY RESULTS OF A PHASE II STUDY OF STEREOTACTIC RADIOSURGERY IN CONJUNCTION WITH THE PD-1 INHIBITOR PEMBROLIZUMAB FOR THE TREATMENT OF RECURRENT HIGH-GRADE MENINGIOMA. Neuro-Oncology. 26(Supplement_8). viii92–viii93. 1 indexed citations
2.
Nguyen, Minh, Ekin Güney, Krishna Bharani, et al.. (2024). High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience. Endocrine Pathology. 35(4). 338–348. 2 indexed citations
3.
O’Brien, Barbara, Marta Peñas-Prado, Carlos Kamiya-Matsuoka, et al.. (2021). CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. Neuro-Oncology. 23(Supplement_6). vi65–vi65. 1 indexed citations
4.
Pham, Lily, Karl Maria Schumacher, Soetkin Vlassak, et al.. (2021). INNV-21. COMPLETE RESPONSE TO ADJUVANT TEPOTINIB IN A PATIENT WITH NEWLY DIAGNOSED DISSEMINATED GLIOBLASTOMA (GBM) HARBORING MET AMPLIFICATION. Neuro-Oncology. 23(Supplement_6). vi109–vi109. 3 indexed citations
5.
Ott, Martina, Cynthia Kassab, Anantha Marisetty, et al.. (2020). Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clinical Cancer Research. 26(18). 4983–4994. 41 indexed citations
6.
Rosenthal, Mark, Paul M. Clément, Mario Campone, et al.. (2020). Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study. ESMO Open. 5(4). e000672–e000672. 27 indexed citations
7.
8.
Barthel, Floris P, Kevin C. Johnson, Frederick S. Varn, et al.. (2019). GENE-28. LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS. Neuro-Oncology. 21(Supplement_6). vi103–vi103. 3 indexed citations
9.
Cachia, David, Nabil Elshafeey, Carlos Kamiya-Matsuoka, et al.. (2017). Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. Journal of Neuro-Oncology. 135(1). 75–81. 14 indexed citations
10.
Mandel, Jacob, Charles A. Conrad, Mark R. Gilbert, et al.. (2014). Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. Journal of Neuro-Oncology. 119(1). 135–140. 24 indexed citations
11.
Wen, Patrick Y., W.K. Alfred Yung, Ingo K. Mellinghoff, et al.. (2014). PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM. Neuro-Oncology. 16(suppl 3). iii47–iii47. 8 indexed citations
12.
Yust‐Katz, Shlomit, Mark D. Anderson, D. Liu, et al.. (2013). Clinical and prognostic features of adult patients with gangliogliomas. Neuro-Oncology. 16(3). 409–413. 33 indexed citations
13.
DeGroot, John, Timothy F. Cloughesy, Jeffrey S. Wefel, et al.. (2011). Clinical trial end points for high-grade glioma: the evolving landscape. Neuro-Oncology. 13(3). 353–361. 89 indexed citations
14.
Wen, Patrick Y., David R. Macdonald, David A. Reardon, et al.. (2010). Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. Journal of Clinical Oncology. 28(11). 1963–1972. 2726 indexed citations breakdown →
15.
Derzon, M. S., Gary E Rochau, John DeGroot, et al.. (2000). An Inertial-Fusion Z-Pinch Power Plant Concept. Nuclear Fusion. 1 indexed citations
16.
DeGroot, John, et al.. (2000). Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation. Neuroreport. 11(3). 497–502. 141 indexed citations
17.
DeGroot, John, R. E. Coggeshall, & Susan M. Carlton. (1997). The reorganization of μ opioid receptors in the rat dorsal horn following peripheral axotomy. Neuroscience Letters. 233(2-3). 113–116. 43 indexed citations
18.
19.
Holden, Joseph T., William D. Grant, & John DeGroot. (1979). Lysozyme sensitivity of pantothenate-deficient Lactobacillus plantarum grown with exogenous fatty acids. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 574(1). 173–176. 2 indexed citations
20.
Lanchantin, Gerard F., Jack Friedmann, John DeGroot, & John W. Mehl. (1963). Preparation of Human Plasma Prothrombin and Some of Its Sedimentation Properties. Journal of Biological Chemistry. 238(1). 238–243. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. C. Tonn Breakdown of academic impact, for papers by Oliver Schnell Breakdown of academic impact, for papers by Melike Pekmezci Breakdown of academic impact, for papers by Martin Glas Breakdown of academic impact, for papers by Geoffrey Barger Breakdown of academic impact, for papers by Ghazaleh Tabatabai Breakdown of academic impact, for papers by Keishi Makino Breakdown of academic impact, for papers by Fábio M. Iwamoto Breakdown of academic impact, for papers by Juan Guillermo Trigo Naranjo Breakdown of academic impact, for papers by M. Kelly Nicholas
Rankless by CCL
2026